Peter Altman - 28 Apr 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
28 Apr 2022
Net transactions value
+$8,004
Form type
4
Filing time
02 May 2022, 08:00:29 UTC
Previous filing
18 Apr 2022
Next filing
13 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $3,657 +2,300 +0.7% $1.59 330,443 28 Apr 2022 Direct F1
transaction BCDA Common Stock Purchase $4,347 +2,700 +0.82% $1.61 333,143 29 Apr 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $1.56 to $1.66 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 This transaction was executed in multiple trades ranging from $1.60 to $1.63 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.